Stay updated on Tolebrutinib in NRSPMS Clinical Trial
Sign up to get notified when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.

Latest updates to the Tolebrutinib in NRSPMS Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision label updated to v3.4.1 and the previous funding-lapse notice (v3.4.0) was removed.SummaryDifference0.1%

- Check25 days agoChange DetectedTwo study location entries in India (122001 and 122002) were updated from Gurgaon to the diacritic spelling Gūrgaon in the study's locations list.SummaryDifference0.1%

- Check32 days agoChange DetectedGlossary display toggle has been added to the page. Updated labels and revision information include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a revision note 'v3.4.0' replacing the previous 'v3.3.4'.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible edits to the study details or page functionality.SummaryDifference0.0%

- Check68 days agoChange DetectedThe Locations section has been updated with numerous new trial sites across the US, Argentina, Australia, Canada, India, and Europe. Several previously listed locations were removed.SummaryDifference2%

Stay in the know with updates to Tolebrutinib in NRSPMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.